Sotera Health Affirms FY2026 Adj EPS Guidance of $0.93-$1.01 vs $0.96 Est; Affirms FY2026 Sales Guidance of $1.233B-$1.251B vs $1.239B Est

Benzinga Newsdesk www.benzinga.com Negative 50.1%

Neg 50.1% Neu 0% Pos 0%

Sotera Health (NASDAQ:SHC) affirms FY2026 Adj EPS guidance from $0.93-$1.01 to $0.93-$1.01 vs $0.96 analyst estimate. Affirms FY2026 sales outlook from $1.233 billion-$1.251 billion to $1.233 billion-$1.251 billion vs $1.239 billion estimate.